NCT02323191 2020-08-27A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid TumorsHoffmann-La RochePhase 1 Completed221 enrolled
NCT02760797 2018-05-22A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid TumorsHoffmann-La RochePhase 1 Completed38 enrolled
NCT01494688 2018-03-16A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid TumorsHoffmann-La RochePhase 1 Completed217 enrolled